Copenhagen, Denmark & Ingelheim, Germany:Phase II dose-finding trial met primary endpoint after 46 weeks of treatment, representing an important advancement of Boehringer...
The landscape of internet browsing stands at a critical crossroads. For decades, web browsers have served as the gateway to online information, with search...